adjusted diluted earnings per share is now expected to be in the range of $num-one to $num-two and reported diluted earnings per share to be in the range of $num-three to $num-four.
for revenue, we are raising and narrowing our guidance range with projected revenue now between $num-one billion and $num-two billion and operational revenue growth of between num-three% and num-four% for the full year versus a negative num-five% to positive num-three% we had in our may guidance.
we generated revenue of $num-one billion, which was flat on a reported basis and num-two% growth operationally.
adjusted diluted earnings per share is now expected to be in the range of $num-one to $num-two and reported diluted earnings per share to be in the range of $num-three to $num-four.
for zoetis, we expect our overall revenue growth for the remainder of the year to be driven largely by companion animal products, especially our parasiticides and key dermatology portfolio.